Abstract:Infectious complications are a common cause of morbidity and mortality in cancer patients undergoing chemotherapy due to increased risk of oral and gastrointestinal candidiasis, candidemia and septicemia. Interactions between C. albicans and endogenous mucosal bacteria are important in understanding the mechanisms of invasive infection. We published a mouse intravenous chemotherapy model that recapitulates oral and intestinal mucositis, and myelosuppression in patients receiving 5-fluorouracil. We used this model to study the influence of C. albicans on the mucosal bacterial microbiome and compared global community changes in the oral and intestinal mucosa of the same mice. We validated 16S rRNA gene sequencing data by qPCR, in situ hybridization and culture approaches. Mice receiving both 5Fu and C. albicans had an endogenous bacterial overgrowth on the oral but not the small intestinal mucosa. C. albicans infection was associated with loss of mucosal bacterial diversity in both sites with indigenous Stenotrophomonas, Alphaproteobacteria and Enterococcus species dominating the small intestinal, and Enterococcus species dominating the oral mucosa. Both immunosuppression and Candida infection contributed to changes in the oral microbiota. Enterococci isolated from mice with oropharyngeal candidiasis were implicated in degrading the epithelial junction protein E-cadherin and increasing the permeability of the oral epithelial barrier in vitro. Importantly, depletion of these organisms with antibiotics in vivo attenuated oral mucosal E-cadherin degradation and C. albicans invasion without affecting fungal burdens, indicating that bacterial community changes represent overt dysbiosis. Our studies demonstrate a complex interaction between C. albicans, the resident mucosal bacterial microbiota and the host environment in pathogenesis. We shed significant new light on the role of C. albicans in shaping resident bacterial communities and driving mucosal dysbiosis.

Depletion and restoration of tissue ATP in hemorrhagic shock.

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

Candida Albicans-Myeloid Cells-T Lymphocytes Axis in the Tumor Microenvironment of Oral Tumor-Bearing Mice

Combinatorial actions of IL-22 and IL-17 drive optimal immunity to oral candidiasis through SPRRs

Effects of Candida Albicans Infection on Defense Effector Secretion by Human Oral Mucosal Epithelial Cells.

Candida Albicans Promotes Oral Cancer Via IL-17A/IL-17RA-Macrophage Axis.

Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection

A Human Commensal-Pathogenic Fungus Suppresses Host Immunity Via Targeting TBK1

Zirconium-95 in Utah vegetation produced during the 1966 growing season.

The Adaptor CARD9 is Required for Adaptive but Not Innate Immunity to Oral Mucosal Candida Albicans Infections (MPF3P.805)

Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization

Different Host Immunological Response to C. Albicans by Human Oral and Vaginal Epithelial Cells

Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin

Candida albicans induces TLR2/MyD88/NF-κB signaling and inflammation in oral lichen planus-derived keratinocytes

Multi-Step Pathogenesis and Induction of Local Immune Response by Systemic Candida Albicans Infection in an Intravenous Challenge Mouse Model

GP IIb/IIIa-Mediated Platelet Activation and Its Modulation of the Immune Response of Monocytes Against Candida Albicans.

Antimicrobial Effect of Extracellular Vesicles Derived From Human Oral Mucosal Epithelial Cells on <i>Candida albicans</i>

Protection Against Epithelial Damage During Candida albicans Infection Is Mediated by PI3K/Akt and Mammalian Target of Rapamycin Signaling

Candida albicans overgrowth disrupts the gut microbiota in mice bearing oral cancer

Non-canonical IL-22 receptor signaling remodels the mucosal barrier during fungal immunosurveillance

IL-17: A Critical Cytokine for Defense against Oral Candidiasis